DNA damage response in tumours of patients with endometrial cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23000

Enrollment

Registered

2019-02-03

Start date

2019-02-03

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

We will collect fresh tumour tissue from patients with endometrial cancer. Patients who received neo-adjuvant chemotherapy will be excluded from the study. We will use only leftover tissue after patho

Eligibility

Inclusion criteria

Inclusion criteria: Patients with all subtypes of endometrial cancer

Exclusion criteria

Exclusion criteria: Patients will be informed upfront that any relevant findings in this study will be reported back to themselves and to their attending physicians. They cannot participate in the study when they do not consent to these criteria.

Design outcomes

Primary

Measure	Time frame
We hope to find a way to perform ex- vivo testing of the respons to several therapies in fresh tumour tissue	—

Contacts

Public ContactLena van Doorn

ErasmusMC Cancer Institute

h.vandoorn@erasmusmc.nl+31630778464

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)